Using an inhibition enzyme linked immunosorbent assay (ELISA) the serum antibody responses against released proteins of yersinia of molecular weights 26 and 46 kilodaltons were studied in 37 patients with and in 21 patients without reactive arthritis foilowing yersinia infection. Although no difference was seen for the 46 kilodalton released protein, patients with yersinia triggered reactive arthritis had higher levels of antibodies against the 26 kilodalton released protein at the beginning of the disease than patients with uncomplicated yersiniosis. This may indicate an increased production of this protein in the early infection leading to poorer phagocytosis of the bacteria and thereby to the persistence of yersinia organisms within the arthritic host.
Reactive arthritis develops as a complication following certain infections including those caused by yersiniae and salmonellae. In the development of reactive arthritis host-microbe interaction is important, but the exact pathogenetic mechanisms of arthritis are largely unknown.' 2 Human pathogenetic strains of the genus Yersinia possess closely related plasmids that control virulence functions.3 Several plasmid encoded proteins have been identified as outer membrane proteins or as secreted proteins (released proteins, RPI to RP5). 4 The procedure was similar to that described previously.'2 Polystyrene microtitre plates (Costar, Cambridge, MA, USA) were coated with the optimum concentration of released proteins (6 tg/ml) in phosphate buffered saline (PBS) and saturated with 1% bovine serum albumin in PBS (1% BSA-PBS). Serum samples were diluted 1:10 in 1% BSA-PBS and incubated on the plates (75 ,ul/well) for two hours at 37°C.
After washing 60 1i of the monoclonal antibody (9- 
